Revion Tirzepatide Pen 90mg
The Revion Tirzepatide Pen 90mg is a dual GIP and GLP-1 receptor agonist research solution tailored for analytical and laboratory studies. Formulated for multi-dose quantitative applications, this 90mg high-capacity pen provides scientific research projects with maximum consistency, structural integrity, and ease of handling across extensive assay runs.
Revion Tirzepatide Pen 90mg Technical Specifications
| Parameter | Specification |
| Brand / Line | Revion / Revion+ Series |
| Active Compound | Tirzepatide (Dual GIP / GLP-1 Receptor Agonist) |
| Total Concentration | 90mg |
| Delivery System | Multi-dose precision click pen device |
| Purity Grade | ≥ 98.5% (HPLC & Mass Spectrometry Verified) |
| Formulation | Lyophilized / Stable Solution for Analytical Testing |
| Storage Temperature | Refrigerated (2°C – 8°C) |
Revion Tirzepatide Pen Price & Laboratory Purchasing
Our Revion tirzepatide pen price model is optimized for research laboratories requiring ongoing batch consistency. We offer individual unit orders as well as scalable bulk pricing for high-volume experimental protocols.
-
Standard Unit Pricing: Live pricing and current stock levels are displayed above.
-
Bulk Laboratory Tiering: Automatic volume pricing adjustments apply at checkout for multi-unit research orders.
-
Certificate of Analysis (COA): Every Revion Tirzepatide Pen 90mg shipment includes lot-specific HPLC reports to confirm purity and mass accuracy.
Dual-Agonist Research Applications & Handling
Receptor Affinity & Research Scope
Tirzepatide is widely studied in metabolic pathways for its simultaneous interaction with Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) receptors. The 90mg total payload provides scientists with extended dosing flexibility without requiring frequent cartridge changes.
Reconstitution & Stability Guidelines
Maintain the Revion Tirzepatide Pen 90mg between 2°C and 8°C to maintain peptide stability. Avoid exposing the device to direct sunlight or ambient heat exceeding 25°C.





